Patient characteristics: American vs Canadian transplant patients

Slides:

Advertisements

Similar presentations

Hazard of incident coronary heart disease by diabetes status, with or without elevation of troponin T No diabetes Pre- diabetes Diabetes No diabetes Pre-

Advertisements

Patient Survival USA Primary DD Pancreas Transplants 1/1/2004 – 12/31/2008 Categoryn 1Yr Surv. PTA % PAK1, % SPK4, % 2/09.

Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345: , 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.

BluntPenetrating Placebo rFVIIa Patients (%) n=20 n=8 n=9 n=4 P=0.03 P=0.068 Adapted from Rizoli S. Canadian Anesthesiologists’

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

USRDS 1998 II , ,515 74,116 51,762 Period Prev. Point Prev. Incidence Deaths LFU** Counts (1000s) Year *Preliminary **Lost-to-Followup Reported.

2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.

Participant Characteristics by Lowest Leg AAI Category Ann M. O’Hare, et al, Circulation 2006;113;

Hsia J et al. J Am Coll Cardiol 2011;57: Baseline Characteristics by Treatment Group and Attained LDL-C Hsia J et al. J Am Coll Cardiol 2011;57:

Shalev V, et al. Arch Intern Med 2009; 169:

Trial profile Prakash Deedwania, et al. Lancet 2006; 368:

Charlotte Kragelund et al N Engl J Med 2005;352: Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.

Is BMI a Justified Contraindication for Kidney Transplantation? Introduction OHSU’s Kidney Transplant Program has set a BMI >35 kg/m 2 as a relative contraindication.

Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Use of Inhaled Corticosteroids and the Risk.

Rapid Fibrosis and Significant Histologic Recurrence of Hepatitis C After Liver Transplant Is Associated With Higher Tumor Recurrence Rates in Hepatocellular.

LEADER trial: Primary Outcome

Hospital admissions per patient, by modality figure 5

Adjusted odds ratio 95% CI Diagnostic angiography PCI CABG

Relative mortality risk associated with quartiles of systolic blood pressure compared with systolic

SAVE: Risk of total mortality associated with reduced kidney function

Adjusted all-cause mortality risk by dialysate sodium (DNa) and predialysis serum sodium (SNa). Adjusted all-cause mortality risk by dialysate sodium (DNa)

Baseline characteristics of patients

Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )

Mean eGFR among survivors after CABG surgery vs all-cause deaths

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

PREMIER: Rate of hypertension at 18 months

Primary care physicians visited chiefly by black patients were more likely to report they were unable to provide high-quality care to all their patients.

Association between highest tertile for homocysteine and mortality

ASCOT-BPLA: Primary and secondary end points

Relative risk of major events with atenolol vs placebo

Health ABC: Mortality risk by quintile of cystatin C

Hazard ratios (HR) for ESRD or death for 1-SD increase in systolic BP: Home recording vs clinic measurement BP measurement HR for each 1-SD increase.

Your Kidneys May Outlive You

Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.

A, Measurement of the angle between the TS-OP line and the hard palate in the lateral scout view of the brain CT (black arrow). A, Measurement of the angle.

Mancini JG, et al. Am J Cardiol.

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

Cystatin C levels and risk of death from all causes

Adjusted 1st-Year Patient Death Rates by

Mintu P. Turakhia et al. JACEP 2016;2:

Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level BP level (mm Hg) Adjusted relative risk 95%

Prabhat Kumar et al. JACEP 2016;j.jacep

Inclusion Criteria for Patients with Multiple Atherothrombotic Risk Factors and for Those with Established Cardiovascular Disease Deepak L.Bhatt, et al,

Overall (n=301) Acute/Subacute (n=149) Late (n=152) p Presentation

Risk factor Treatment GFR at baseline GFR at 5 years p Cadaveric donor

Christina L. Klein, MD, Daniel C. Brennan, MD, FACP

Nat. Rev. Cardiol. doi: /nrcardio

Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.

Patient Disposition James A. de Lemos et al. JAMA 2004; 292:

Receiver operating characteristic curves for the association of primary outcome using each clinical risk score and each clinical risk score adjusted for.

IMPRESS Trial design: Patients undergoing primary PCI for STEMI and cardiogenic shock were randomized in a 1:1 to either Impella CP or IABP. They were.

Figure 2. Odds ratios (ORs) from the multivariate logistic regression analysis and hazard ratios (HRs) from the Cox regression analysis Odds ratios (ORs)

Relationship between selected metabolic parameters and the primary composite end point. Relationship between selected metabolic parameters and the primary.

EMPA-REG OUTCOME: Cumulative incidence of the primary outcome

Davide Capodanno et al. JCIN 2009;2:

Pooled risk with 95% CI of ACM (A) and CVD risk (B) for the highest vs

Immunosuppression significantly reduced all-cause mortality or risk of ESRD (A) and significantly increased complete or partial remission (B) at the end.

The risk of graft failure is highest for sex mismatched donors and recipients when the recipient body surface area is greater than the donor. The risk.

Christian Madelaire et al. JCHF 2018;6:

Increase of physical activity over time associated with lower HF risk

Characteristics of 3415 patients admitted to hospital with

Orly Vardeny et al. JCHF 2016;4:

Risk of type 2 diabetes as a function of ABCA1 and ABCG1 genotype in CCHS. Hazard ratios were multifactorially adjusted for age, sex, BMI, hypertension,

Incidence of DM as a function of TyG index (white bars) or TG/HDL-C ratio (black bars). Incidence of DM as a function of TyG index (white bars) or TG/HDL-C.

Risk of mortality in patients with diabetes and ESRD

Avasare et al. Am J Nephrol 2017;45:99-106 (DOI: / )

Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.

Mortality risk by age at study entry across DOPPS regions.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

The risk of graft failure is highest for sex mismatched donors and recipients when the recipient weight is greater than the donor. The risk of graft failure.

Presentation transcript:

Patient characteristics: American vs Canadian transplant patients US patients Canadian patients White patients (%) 71 82 Black patients (%) 23 3 DM as primary cause of ESRD (%) 18 Cadaveric graft (%) 70 76 Kim S et al. Am J Transplant 2006; 6:109-114.

Mortality risk: American vs Canadian transplant patients End point Hazard ratio (95% CI) p Overall adjusted posttransplant mortality 1.35 (1.24–1.47) <0.005 Mortality in first year posttransplant 1.09 0.30 Mortality beyond the first year posttransplant 1.49–1.53 Kim S et al. Am J Transplant 2006; 6:109-114.